PortfoliosLab logo

Global Blood Therapeutics, Inc. (GBT)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US37890U1088
CUSIP
37890U108

GBTPrice Chart


Chart placeholderClick Calculate to get results

GBTPerformance

The chart shows the growth of $10,000 invested in Global Blood Therapeutics, Inc. on Aug 13, 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,785 for a total return of roughly -32.15%. All prices are adjusted for splits and dividends.


GBT (Global Blood Therapeutics, Inc.)
Benchmark (S&P 500)

GBTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.50%0.43%
6M-24.57%9.37%
YTD-32.46%22.33%
1Y-33.30%26.59%
5Y9.54%15.74%
10Y-5.98%13.38%

GBTMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

GBTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Global Blood Therapeutics, Inc. Sharpe ratio is -0.60. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


GBT (Global Blood Therapeutics, Inc.)
Benchmark (S&P 500)

GBTDividends


Global Blood Therapeutics, Inc. doesn't pay dividends

GBTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


GBT (Global Blood Therapeutics, Inc.)
Benchmark (S&P 500)

GBTWorst Drawdowns

The table below shows the maximum drawdowns of the Global Blood Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Global Blood Therapeutics, Inc. is 76.31%, recorded on Feb 9, 2016. It took 484 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.31%Nov 19, 201555Feb 9, 2016484Jan 10, 2018539
-70.86%Jan 17, 2020434Oct 6, 2021
-52.14%Feb 21, 2018198Nov 30, 2018249Nov 27, 2019447
-29.44%Aug 18, 201529Sep 28, 201537Nov 18, 201566
-9.46%Aug 13, 20151Aug 13, 20151Aug 14, 20152
-8.34%Jan 30, 20189Feb 9, 20184Feb 15, 201813
-7.95%Jan 16, 20181Jan 16, 20185Jan 23, 20186
-5.34%Dec 9, 20191Dec 9, 201910Dec 23, 201911
-4.02%Dec 27, 20194Jan 2, 20204Jan 8, 20208
-3.08%Jan 10, 20202Jan 13, 20201Jan 14, 20203

GBTVolatility Chart

Current Global Blood Therapeutics, Inc. volatility is 36.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


GBT (Global Blood Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Global Blood Therapeutics, Inc.


Loading data...

More Tools for Global Blood Therapeutics, Inc.